The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.